INHALED DRY POWDER BUDESONIDE

Clinical Indication

Covid 19 treatment commenced in primary care for patients 50 years and over.

Comments

In line with CAS alert 103154 

See CAS alert and alert attachments for more information including eligibility and duration of treatment and  also see the formulary

 

Date of classification

April 2021

Review date

April 2021

Green

Drugs for which GPs would normally take full responsibility for prescribing and monitoring. Drugs included in this list have been specifically considered by LMSG.